infused < infusion < infusional

Facettes :

List of bibliographic references

Number of relevant bibliographic references: 22.
[0-20] [0 - 20][0 - 22][20-21][20-40]

Ident.	Authors (with country if any)	Title
000120 (2011)	Diego Santos-García [Espagne] ; Mercedes Macías [Espagne] ; Miguel Llaneza [Canada] ; M Nica Grande [Espagne] ; Raúl De La Fuente-Fernández [Canada]	Serum vitamin B12 and folate levels in Parkinson's disease patients treated with duodenal levodopa infusion
000333 (2011)	Fabian Klostermann [Allemagne] ; Constanze Jugel [Allemagne] ; Frank Marzinzik [Allemagne]	Jejunal levodopa infusion in long‐term DBS patients with Parkinson's disease
000C27 (2009)	Julia Vaamonde [Espagne] ; José M. Flores [Espagne] ; Roberto Weisser [Espagne] ; Ram N Iba Ez [Espagne] ; José A. Obeso [Espagne]	The duration of the motor response to apomorphine boluses is conditioned by the length of a prior infusion in Parkinson's disease
000C44 (2009)	Diego Santos-García [Espagne] ; Mercedes Macías [Espagne] ; Miguel Llaneza [Espagne] ; Ángel Aneiros [Espagne]	Suicide following duodenal levodopa infusion for Parkinson's disease
000D41 (2009)	David Devos [France]	Patient profile, indications, efficacy and safety of duodenal levodopa infusion in advanced Parkinson's disease
000E48 (2009)	Holger Honig [Allemagne] ; Angelo Antonini [Italie] ; Pablo Martinez-Martin [Espagne] ; Ian Forgacs [Royaume-Uni] ; Guy C. Faye [Royaume-Uni] ; Thomas Fox [Allemagne] ; Karen Fox [Allemagne] ; Francesca Mancini [Italie] ; Margherita Canesi [Italie] ; Per Odin [Allemagne] ; K. Ray Chaudhuri [Royaume-Uni]	Intrajejunal levodopa infusion in Parkinson's disease: A pilot multicenter study of effects on nonmotor symptoms and quality of life
001214 (2008)	Birgit Meiler [Allemagne] ; Jürgen Andrich [Allemagne] ; Thomas Müller [Allemagne]	Rapid switch from oral antiparkinsonian combination drug therapy to duodenal levodopa infusion
001432 (2008)	Pedro J. García Ruiz [Espagne] ; Ángel Sesar Ignacio [Espagne] ; Bego A Ares Pensado [Espagne] ; Alfonso Castro García [Espagne] ; Fernando Alonso Frech [Espagne] ; Mercedes Álvarez L Pez [Espagne] ; José Arbelo González [Espagne] ; Joan Baiges Octavio [Espagne] ; Juan Andrés Burguera Hernández [Espagne] ; Matilde Calopa Garriga [Espagne] ; Dulce Campos Blanco [Espagne] ; Belén Casta O García [Espagne] ; Manuel Carballo Cordero [Espagne] ; José Chac N Pe A [Espagne] ; Anna Espino Ibá Ez [Espagne] ; Aránzazu Gorospe Onisalde [Espagne] ; Santiago Giménez-Roldán [Espagne] ; Pilar Granés Ibá Ez [Espagne] ; Jorge Hernández Vara [Espagne] ; Ram N Ibá Ez Alonso [Espagne] ; Félix Javier Jiménez Jiménez [Espagne] ; Jerzy Krupinski [Espagne] ; Jaime Kulisevsky Bojarsky [Espagne] ; Inés Legarda Ramírez [Espagne] ; Elena Lezcano García [Espagne] ; Juan Carlos Martínez-Castrillo [Espagne] ; Dolores Mateo González [Espagne] ; Francesc Miquel Rodríguez [Espagne] ; Pablo Mir [Espagne] ; Elena Mu Oz Fargas [Espagne] ; José Obeso Inchausti [Espagne] ; Jesús Olivares Romero [Espagne] ; José Olivé Plana [Espagne] ; Pilar Otermin Vallejo [Espagne] ; Berta Pascual Sedano [Espagne] ; Víctor Pérez De Colosía Rama [Espagne] ; Isabel Pérez L Pez-Fraile [Espagne] ; Albert Planas Comes [Espagne] ; Víctor Puente Periz [Espagne] ; María Cruz Rodríguez Oroz [Espagne] ; Dolores Sevillano García [Espagne] ; Pilar Solís Pérez [Espagne] ; José Suárez Mu Oz [Espagne] ; Julia Vaamonde Gamo [Espagne] ; Caridad Valero Merino [Espagne] ; Francesc Valldeoriola Serra [Espagne] ; José Miguel Velázquez Pérez [Espagne] ; Rosa Yá Ez Ba A [Espagne] ; Ivana Zamarbide Capdepon [Espagne]	Efficacy of long‐term continuous subcutaneous apomorphine infusion in advanced Parkinson's disease with motor fluctuations: A multicenter study
001690 (2007)	Carmine Vitale [Italie] ; Stefano Marconi [Italie] ; Luigi Di Maio [Italie] ; Giuseppe De Michele [Italie] ; Katia Longo [Italie] ; Vincenzo Bonavita [Italie] ; Paolo Barone [Italie]	Short‐term continuous infusion of apomorphine hydrochloride for treatment of Huntington's chorea: A double blind, randomized cross‐over trial
001987 (2007)	Angelo Antonini [Italie] ; Ioannis U. Isaias [Italie] ; Margherita Canesi [Italie] ; Maurizio Zibetti [Italie] ; Francesca Mancini [Italie] ; Luigi Manfredi [Italie] ; Marco Dal Fante [Italie] ; Leonardo Lopiano [Italie] ; Gianni Pezzoli [Italie]	Duodenal levodopa infusion for advanced Parkinson's disease: 12‐month treatment outcome
001D72 (2006)	Pedro J. Garcia Ruiz [Espagne]	Nocturnal subcutaneous apomorphine infusion for severe insomnia in Parkinson's disease
002341 (2005)	Nicolas Simon [France] ; Joëlle Micallef [France] ; Jean-Charles Reynier [France] ; Monique Lesourd [France] ; Tatiana Witjas [France] ; André Alicherif [France] ; Jean-Philippe Azulay [France] ; Olivier Blin [France]	End‐of‐dose akinesia after a single intravenous infusion of the dopaminergic agonist piribedil in Parkinson's disease patients: A pharmacokinetic/pharmacodynamic, randomized, double‐blind study
002746 (2004)	Montse Alegret [Espagne] ; Francesc Valldeoriola [Espagne] ; Majosé Martí [Espagne] ; Manuela Pilleri [Espagne] ; Carme Junqué [Espagne] ; Jordi Rumià [Espagne] ; Eduardo Tolosa [Espagne]	Comparative cognitive effects of bilateral subthalamic stimulation and subcutaneous continuous infusion of apomorphine in Parkinson's disease
003200 (2000)	Pieter Joost Van Wattum [États-Unis] ; Phillip B. Chappell [États-Unis] ; Daniel Zelterman [États-Unis] ; Lawrence D. Scahill [États-Unis] ; James F. Leckman [États-Unis]	Patterns of response to acute naloxone infusion in Tourette's syndrome
003496 (1999)	Fabrizio Stocchi ; Carlo Farina [Italie] ; Gianpietro Nordera [Italie] ; Stefano Ruggieri	Implantable venous access system for apomorphine infusion in complicated Parkinson's disease
003620 (1998)	van Laar ; Bob Van Hilten ; Cees Neef ; A. Wijnand F. Rutgers ; Stan Pavel ; J. Anthony Bruijn	The role of EDTA in provoking allergic reactions to subcutaneous infusion of apomorphine in patients with Parkinson's disease: A histologic study
003C93 (1995)	Maricle [États-Unis] ; John G. Nutt [États-Unis] ; Julie H. Carter [États-Unis]	Mood and anxiety fluctuation in Parkinson's disease associated with levodopa infusion: Preliminary findings
004303 (1991)	Pezzoli [Italie] ; Anna Zecchinelli [Italie, États-Unis] ; Sante Ricciardi [Italie] ; Robert E. Burke [États-Unis] ; Stanley Fahn [États-Unis] ; Guglielmo Scarlato [Italie] ; Angelo Carenzi [Italie]	Intraventricular infusion of epidermal growth factor restores dopaminergic pathway in hemiparkinsonian rats
004384 (1990)	M. E. Rodriguez [Espagne] ; M. R. Luquin [Espagne] ; G. Lera [Espagne] ; G. Delgado [Espagne] ; J. M. Salazar [Espagne] ; Obeso [Espagne]	Neuroleptic malignant syndrome treated with subcutaneous lisuride infusion
004418 (1990)	J. Vaamonde [Espagne] ; M. R. Luquin [Espagne] ; Obeso [Espagne]	Dopaminergic responsiveness to apomorphine after chronic treatment with subcutaneous lisuride infusion in Parkinson's disease
004570 (1987)	de Yebenes [États-Unis] ; Stanley Fahn [États-Unis] ; Vernice Jackson-Lewis [États-Unis] ; Maria Angeles Mena [États-Unis]	The effect of intracerebroventricular infusion of (+)‐4‐propyl‐9‐hydroxynapthoxacine (PHNO) through a totally implanted drug delivery system in rats with dopamine deficiency

---

Pour manipuler ce document sous Unix (Dilib)

EXPLOR_STEP=$WICRI_ROOT/Wicri/Santé/explor/MovDisordV3/Data/Istex/Checkpoint

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i -k "infusion" 

HfdIndexSelect -h $EXPLOR_AREA/Data/Istex/Checkpoint/Title.i  \
                -Sk "infusion" \
         | HfdSelect -Kh $EXPLOR_AREA/Data/Istex/Checkpoint/biblio.hfd 

Pour mettre un lien sur cette page dans le réseau Wicri

{{Explor lien
   |wiki=    Wicri/Santé
   |area=    MovDisordV3
   |flux=    Istex
   |étape=   Checkpoint
   |type=    indexItem
   |index=    Title.i
   |clé=    infusion
}}

---

This area was generated with Dilib version V0.6.23. Data generation: Sun Jul 3 12:29:32 2016. Site generation: Wed Feb 14 10:52:30 2024